Financial PerformanceThe company's 3Q24 revenue was below expectations due to unforeseen reimbursement headwinds.
Price TargetUnforeseen headwinds in receiving reimbursement from payors have caused a tempering of the 12-month outlook and a lowered price target.
Reimbursement ChallengesThe publication of interim results from the company’s post-market study, anticipated by the end of 3Q24, could serve as a significant catalyst as favorable safety and efficacy data can be leveraged in discussions with insurance payors to secure reimbursement for Catamaran procedures.